Biogen Ventures Into Value-Based Contracts In Multiple Sclerosis

Four contracts test approaches tying reimbursement to relapse rates and discontinuation of treatment. Payers involved include Harvard Pilgrim and Intermountain's SelectHealth.

More from Market Access

More from Pink Sheet